about
Improvement of semi-quantitative small-animal PET data with recovery coefficients: a phantom and rat study.Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer.Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenografts.Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System.Oxidative stress disassembles the p38/NPM/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response.Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma.Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens.Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis.Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents
P50
Q31122939-AD9E2C44-871E-4731-8EF9-DCBB977473E5Q36254165-470E6D72-6E8E-4346-AEA9-905F176BBC76Q37236032-4A3FDE44-5D23-4B53-ADE1-DF53D5BBC404Q39155020-4A8D8E36-4578-4FE1-8914-B31834E55829Q39720176-EDDDBA3E-71F9-4856-8430-378F5F67A811Q39779479-D69986A5-711C-4A8D-9111-36AB66450E85Q39909714-3B86FA88-1B86-4133-8A8A-21C18C498815Q39941723-0993AAFF-79C7-4599-B7C2-D8C296A9FDC8Q40478992-35BF8BC1-60E4-43AC-8DA1-FB8B6999B18DQ41737043-BAA150A2-4940-42F0-AB12-775A5734AEBBQ42492672-30BEBD88-C1F4-4F94-834A-C8D9605D25B4Q42704678-5E55648A-6A3D-495F-A752-5B6134EBA97BQ45259839-EC590B4F-56B9-4F8D-9FCD-7954AAF1F3DBQ45826092-B8573129-126E-4EB8-9B92-F3BC481DD9BBQ50423294-B74BB465-BEEB-4132-9ACD-CFFC2083CA11Q51145591-56A3A471-9AC4-4630-B496-5CC61B589C41Q81074119-E34DDAB5-4BE5-4E67-A0A8-67274BF3E479
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Soizic Dutoit
@en
Soizic Dutoit
@nl
type
label
Soizic Dutoit
@en
Soizic Dutoit
@nl
prefLabel
Soizic Dutoit
@en
Soizic Dutoit
@nl
P31
P496
0000-0003-1094-7823